Colorectal Cancer Drugs Market Opportunities, Business Forecast To 2030
The report " Colorectal Cancer Drugs Market by Therapy (Adjuvant Chemotherapy, Palliative Chemotherapy, Immuno Therapy, Neo Adjuvant Chemotherapy), by Drug Type (Capecitabine, Irinotecan, Fluorouracil, Trifluridine/Tipiracil, Oxaliplatin, Others), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), Region - Global Forecasts to 2030", is projected to reach USD 15.5 billion in 2023, having grown at a Compound Annual Growth Rate (CAGR) of 8.5% during the forecast period 2024-2030. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=16028 Competitive Dashboard: The prominent key players operating in the global colorectal cancer drugs market are Amgen Inc. (U.S) Bristol-Myers Squibb Company (U.S) F. Hoffmann-La Roche Ltd. (Switzerland) Bayer AG (Germany) Merck & Co., Inc. (U.S) Sanofi (France) Regional Overview: The report also examines the current concerns and their Future Ef...